OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 43 filers reported holding OCUPHIRE PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,232,812 | -16.9% | 368,003 | +7.6% | 2.32% | -3.6% |
| Q2 2023 | $1,483,671 | +16.2% | 341,860 | +0.4% | 2.40% | +11.5% |
| Q1 2023 | $1,276,976 | +10.0% | 340,526 | +3.5% | 2.16% | +32.2% |
| Q4 2022 | $1,161,264 | +81.2% | 328,970 | +2.7% | 1.63% | +128.3% |
| Q3 2022 | $641,000 | +7.4% | 320,332 | +3.0% | 0.71% | +16.9% |
| Q2 2022 | $597,000 | +48.1% | 311,120 | +149.8% | 0.61% | +97.1% |
| Q1 2022 | $403,000 | +45.5% | 124,544 | +67.4% | 0.31% | +55.8% |
| Q4 2021 | $277,000 | – | 74,420 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 397,036 | $2,306,000 | 0.64% |
| Regency Capital Management Inc.\DE | 17,000 | $99,000 | 0.10% |
| NORRIS PERNE & FRENCH LLP/MI | 78,909 | $458,000 | 0.04% |
| Ikarian Capital, LLC | 119,551 | $693,000 | 0.02% |
| Stokes Family Office, LLC | 12,120 | $70,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 57,536 | $334,000 | 0.01% |
| MCF Advisors LLC | 9,499 | $55,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $78,000 | 0.00% |
| Renaissance Technologies | 113,620 | $660,000 | 0.00% |
| COMERICA BANK | 30,000 | $143,000 | 0.00% |